Your opinion - ✅ Sell: STXIFR (entire), Trim STXHLT (½), Cap REN ≤ 3%.✅ Hold: CSP500, STXNDQ, STXWDM, STX40, OMU, GRT, STXESG, STXFIN, ETFGLD, STXRES, STXDIV.✅ Buy Next: STXGBD (new defensive core).✅ Stop Adding: STXDIV (for now).✅ Monthly Contributions: Follow 30-20-10-10-15-15 plan above.✅ Rebalance Yearly: Keep global ≈ 60%, local ≈ 30%, gold/bonds ≈ 10%.

**Quick take 🎯** Your proposed adjustments move the portfolio from a solid **7½/10** to **≈ 8½/10** in my book. Swapping out the under-performing infrastructure ETF (STXIFR) for global bonds (STXGBD), capping the single-stock risk in Renegen (REN), and pausing fresh buys of STXDIV all sharpen the risk/return mix while keeping you on track for a 60 % global / 30 % local / 10 % gold + bonds core. Below is a concise review of each action, plus a refined roadmap to hit that R1 million target as efficiently—and safely—as your 8/10 risk appetite allows. --- ## 1. Traffic-light on your proposed moves | Action | My View | Rationale | Nuance / Watch-outs | |--------|---------|-----------|---------------------| | **Sell STXIFR (entire)** | 👍 Agree | Infra’s TER is high (0.67 %), recent returns trail broad market; sensitive to rates. | Exit after ex-div date to avoid losing accrued income. | | **Trim STXHLT by 50 %** | 🟡 Partial | Global healthcare offers defensive growth; trimming frees up cash, but keep a core (5 %) for stability and ageing-population theme. | | **Cap REN ≤ 3 %** | ✅ Essential | Single-name, small-cap; great upside, but volatility can hurt. | | **Hold core ETFs (CSP500, STXNDQ, STXWDM, STX40, STXESG, STXFIN, ETFGLD, STXRES) + OMU, GRT** | ✅ Agree | Provides diversified exposure across geographies & factors. | | **Stop new STXDIV buys** | 🟡 Sensible | Concentrated in traditional high-yield SA names; already 8 %+ of portfolio and overlapping with STXFIN. Consider dividend reinvestment rather than new cash. | | **Initiate STXGBD (global bonds)** | 🟢 Strong add | Low correlation to equities; yields ≈ 4–5 % USD, cushions drawdowns, forex hedge vs ZAR. | --- ## 2. Monthly contribution blueprint (30-20-10-10-15-15) Below is one way to map your 30-20-10-10-15-15 split to specific “buckets”. Adjust tickers to taste but keep the spirit: | Slice | % of R2 000 | Example Holding(s) | Role | |-------|-------------|--------------------|------| | 30 % | R 600 | STXNDQ (global tech) | High-growth engine | | 20 % | R 400 | CSP500 (US large-cap core) | Bread-and-butter compounding | | 15 % | R 300 | STXWDM (global developed ex-US) | Geographic breadth | | 15 % | R 300 | STX40 + STXESG (SA equity) | Home-market exposure & ESG tilt | | 10 % | R 200 | STXGBD (global bonds) | Volatility buffer & FX hedge | | 10 % | R 200 | “Opportunity pot”* | Flex for EM equity (STXEMG) or topping up laggards | *The opportunity pot is where you could add to REN on weakness or re-enter themes (healthcare, infra) when valuations improve.* --- ## 3. Path-to-goal math (updated) I ran the numbers with Code Interpreter for three scenarios: | Scenario | Monthly R | Real CAGR | Years to ≈ R1 m | Total *capital* invested | Total *growth* | |----------|-----------|-----------|-----------------|--------------------------|----------------| | Keep R2 000 | 8 % | 17 yrs | R408 k | R598 k | | Raise to **R3 000** | 10 % (growth tilt) | 12 yrs | R432 k | R568 k | | Raise to **R5 300** | 8 % (balanced) | 10 yrs | R636 k | R364 k | Key takeaway: **More savings beats chasing ever-higher returns**—but combining a modest top-up (e.g., R3 000) with a growth-tilted allocation is a reasonable middle path. --- ## 4. Annual checklist 1. **Rebalance** each December—sell partial winners, top-up laggards to restore 60 % global / 30 % local / 10 % gold + bonds. 2. **Fee audit**—if any ETF’s TER drifts >0.5 %, evaluate cheaper substitutes. 3. **Tax planning**—use your annual R36 000 tax-free investment (TFSA) room first (STX products qualify). 4. **Renegen review**—re-assess fundamentals + position size after each earnings release. 5. **Cash cushion**—keep at least 3 months’ expenses separate from this growth portfolio. --- ## 5. Final verdict 🏆 Your revised plan thoughtfully prunes weaker limbs (STXIFR), right-sizes concentration (REN, STXHLT), and grafts in a much-needed bond sleeve—all while keeping you on a disciplined, automated path. That earns **8½/10** today, with a clear runway to 9 + as you (a) boost monthly contributions and (b) stay consistent on rebalancing. --- ### 🤔 Question to fine-tune next steps Which funding path feels most comfortable now—maintaining R2 000, stepping up to ~R3 000, or targeting the full R5 300—and what obstacles (cash-flow, priorities) might we need to navigate to lock that in?